๐Ÿ”Ž Trials Near Me

Home โ€บ Leukemia

Leukemia clinical trials recruiting in the U.S.

102 studies for Leukemia are recruiting participants at sites across the United States.

Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.

Cities with the most studies

By state

Recently updated studies

Rutgers University Study of the Genetics of Blood Cancers

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 110 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07714044

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

RecruitingPhase 3
Ages 18 to 71 ยท All sexes ยท Updated Sep 23, 2026 ยท NCT07504458

Natural History Study of GATA2 Deficiency and Related Disorders

RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 ยท All sexes ยท Updated Sep 22, 2026 ยท NCT01905826

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

RecruitingPhase 1
Up to age 75 ยท All sexes ยท Updated Sep 16, 2026 ยท NCT06345027

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 16, 2026 ยท NCT06824168

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
30 Days ยท All sexes ยท Updated Sep 16, 2026 ยท NCT04065399

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

RecruitingPhase 1
Up to age 25 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT06810583

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 15, 2026 ยท NCT04996875

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Sep 11, 2026 ยท NCT06229912

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 9, 2026 ยท NCT06907797

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

RecruitingPhase 2
Ages 1 to 18 ยท All sexes ยท Updated Sep 2, 2026 ยท NCT07354074

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

RecruitingPhase 1
Ages 1 to 25 ยท All sexes ยท Updated Sep 1, 2026 ยท NCT06408194

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older ยท All sexes ยท Updated Aug 31, 2026 ยท NCT05237986

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 28, 2026 ยท NCT07284433

CIML NK Cells With Venetoclax for AML

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 28, 2026 ยท NCT06152809

Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia

RecruitingPhase 1
Ages 18 to 90 ยท All sexes ยท Updated Aug 26, 2026 ยท NCT07439211

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

RecruitingPhase 1
18 Months โ€“ 39 Years ยท All sexes ยท Updated Aug 21, 2026 ยท NCT07573111

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 20, 2026 ยท NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Aug 20, 2026 ยท NCT07007312

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Recruiting
Ages 19 and older ยท All sexes ยท Updated Aug 19, 2026 ยท NCT04898790

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.